Applied Biosafety
Share

Applied Biosafety

Published in Association with ABSA International
Journal of ABSA International

Editor
Barbara Johnson Biosafety Biosecurity International, Merritt Island, FL, USA
Karen B. Byers Dana-Farber Cancer Institute, Boston, MA, USA


eISSN: 24701246 | ISSN: 15356760 | Current volume: 22 | Current issue: 1 Frequency: Quarterly

Applied Biosafety: Journal of ABSA International (APB) is a peer-reviewed scientific journal committed to promoting global biosafety awareness and best practices to prevent occupational exposures and adverse environmental impacts related to biohazardous releases. A goal of Applied Biosafety is to provide a forum for exchange of sound biosafety and biosecurity initiatives through publication of original research, review articles, editorials, and special features. We welcome and encourage submissions which further the profession of biosafety.

This journal is a member of the Committee on Publication Ethics (COPE).

Applied Biosafety: Journal of ABSA International (APB) is a peer-reviewed scientific journal committed to promoting global biosafety awareness and best practices to prevent occupational exposures and adverse environmental impacts related to biohazardous releases. A goal of Applied Biosafety is to provide a forum for exchange of sound biosafety and biosecurity initiatives through publication of original research, review articles, editorials, and special features. We welcome and encourage submissions which further the profession of biosafety.

Coeditors-in-Chief
Karen B. Byers Dana-Farber Cancer Institute, Boston, MA, USA
Barbara Johnson Biosafety Biosecurity International, Merritt Island, FL, USA
Associate Editor
David Gillum Arizona State University, Tempe, AZ, USA
International Editors
Stuart D. Blacksell Mahidol-Oxford Tropical Medicine research Unit, Bangkok, Thailand
Luis Alberto Ochoa Carrera Institute for Epidemiological Diagnosis and Reference, Ministry of Health, Mexico City, Mexico
Daniel Kümin Institute of Virology and Immunology, Mittelhäusern, Switzerland
Dewi K. Rowlands Laboratory Animal Services Centre, The Chinese University of Hong Kong, Shatin, Hong Kong
Steven Theriault Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Vijayalaxmy Vijayan Duke-NUS Graduate Medical School, Singapore, Singapore
L. Michael Weaver International Science and Technology Center, Bishkek, Kazakhstan
Managing Editor
Karen D. Savage ABSA International, Mundelein, IL, USA
Editorial Review Board
Allan Bennett Health Protection Agency, Salisbury, Wiltshire, UK
Sherry S. Bohn University of Maryland, College Park, MD, USA
Mary L. Cipriano Biosafety Consultant, Wilmette, IL, USA
Patrick Condreay Biosafety Consultant, Carrboro, NC, USA
Nicole E. Duffee American Association for Laboratory Animal Science, Memphis, TN, USA
Robert P. Ellis Colorado State University, Fort Collins, CO, USA
Richard C. Fink Biosafety Consultant, Andover, MA, USA
Elizabeth Gilman Duane Environmental Health & Engineering, Needham Heights, MA, USA
Felix K. Gmuender Basler & Hofmann AG, Zürich, Switzerland
Raymond W. Hackney, Jr. Durham, NC, USA
Philip Hagan Georgetown University, Washington, DC, USA
Juliette Hanson Ohio State University, Wooster, OH, USA
Robert J. Hawley Biosafety/Biosecurity Consultant, Frederick, MD, USA
Richard Henkel Centers for Disease Control and Prevention, Atlanta, GA, USA
Debra L. Hunt Duke University, Durham, NC, USA
Joany Jackman Johns Hopkins University Applied Physics Laboratory, Laurel, MD, USA
Paul Jennette Cornell University, Ithaca, NY, USA
James Johnston Brigham Young University, Provo, UT, USA
Paul Kivistik University of Nevada, Reno, NV, USA
Thomas A. Kost Biosafety Consultant, Golden, CO, USA
Joseph P. Kozlovac USDA-ARS, Beltsville, MD, USA
Jay Krishnan Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Jens H. Kuhn National Institutes of Health, Frederick, MD, USA
Thomas Leonard University of Virginia, Charlottesville, VA, USA
Timothy D. Mandrell University of Tennessee Health Science Center, Memphis, TN, USA
Alexander McAdam Boston Children’s Hospital, Boston, MA, USA
Paul J. Meechan OSHE Director, Atlanta, GA, USA
Farhad Memarzadeh National Institutes of Health, Bethesda, MD, USA
Theodore Myatt University of Rhode Island, Kingston, RI, USA
Michael A. Pentella William A. Hinton State Laboratory Institute, Jamaica Plain, MA, USA
Matthew S. Philpott Oregon State University, Corvallis, OR, USA
Richard Rebar GlaxoSmithKline, King of Prussia, PA, USA
James V. Rogers Battelle Memorial Institute, Columbus, OH, USA
Kathrin Summermatter Institute of Virology and Immunoprophylaxis, Mittelhäusern, Switzerland
Steven Theriault Public Health Agency of Canada, Winnipeg, Manitoba, Canada
John Tonkiss Boston University, Boston, MA, USA
Donald Vesley University of Minnesota, Minneapolis, MN, USA
Catherine L. Wilhelmsen USAMRIID, Fort Detrick, MD, USA
Dawn P. Wooley Wright State University, Dayton, OH, USA
  • Scopus
  • Manuscript Submission Guidelines: Applied Biosafety: Journal of ABSA International

    Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/apb to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Only manuscripts of sufficient quality that meet the aims and scope of Applied Biosafety will be reviewed.

    Applied Biosafety: Journal of ABSA International (APB) is a peer-reviewed, scientific journal committed to promoting global biosafety awareness and best practices to prevent occupational exposures and adverse environmental impacts related to biohazardous releases. A goal of Applied Biosafety is to provide a forum for exchange of sound biosafety and biosecurity initiatives through publication of original research, review articles, editorials, and special features. We welcome and encourage submissions which further the profession of biosafety.

    The intended audiences for Applied Biosafety are those professional communities that have scientific, strategic and operational responsibilities for biosafety and biosecurity, to include researchers, biosafety professionals, policymakers, architects, engineers, infection control professionals, manufacturers, and industrial hygienists.

    The Coeditors-in-Chief and International Editors encourage submissions to the Journal from professionals in these fields and others who have the responsibility or opportunity to improve biosafety.

    Applied Biosafety is a member of the Committee on Publication Ethics, and strives to follow best practices. There are no fees payable to submit or publish manuscripts in this journal, with the exception of printed color images (see Section 4.6 for details).

    Articles published in Applied Biosafety become open-access two years after publication; arrangements for immediate open-access may be made with SAGE (see Section 3.3).

    1. Article Types
    2. Editorial Policies
        2.1 Peer review policy
        2.2 Authorship
        2.3 Acknowledgments
        2.4 Funding
        2.5 Declaration of Conflicting Interests
        2.6 Research Ethics and Patient Consent
        2.7 Clinical Trials
        2.8 Research Involving Animals
        2.9 Dual Use Agents of Concern
    3. Publishing Polices
        3.1 Publication Ethics
        3.2 Contributor’s Publishing Agreement
        3.3 Open Access and Author Archiving
        3.4 Permissions
    4. Manuscript Preparation
        4.1 Word Processing Formats
        4.2 Journal Style
        4.3 Title, Keywords, and Abstracts
        4.4 Author Names, Affiliations, and Corresponding Author
        4.5 References
        4.6 Artwork Guidelines
        4.7 Guidelines for Submitting Supplemental Files
        4.8 Maximizing Online Discoverability
        4.9 English Language Editing Services
    5. How to Submit Your Manuscript
    6. Upon Acceptance and Publication
        6.1 SAGE Production
        6.2 E-prints
        6.3 OnlineFirst publication
        6.4 Promoting Your Article
    7. Further Information

    1. Article Types

        • Original articles, reports, and case studies should range from 3,000 to 5,000 words (excluding the abstract, tables, figures). In addition to presenting the methods and results of a study, the author(s) should draw implications from the results, discuss their relevance, and propose recommendations for change or further study. Work involving pathogens or toxins must be conducted in accordance with relevant biosafety guidelines, and a statement on the containment used to conduct the experiment should be included.

        • Review articles of a scientific concept or technological application of relevance to biosafety, biocontainment or biosecurity may be up to 6,000 words in length (excluding the abstract and references).

        • Editorials and commentaries may be on any issue of relevance to biosafety but should be no more than 2,500 words—and include appropriate references.

        • Submissions to Special Features: Animal Bytes, Beyond Traditional Biosafety, Biosafety Tips, Capsule, Containment Talk, Green Genes, and Molecular Biosafety. Please see the columns in the Journal for descriptions of the content. The Associate Editor manages the review process for the Special Features columns.

        • Book Reviews should be up to 1,000 words and present reviews of current books.

        • Letters to the Editors should be no more than 300 words and may be edited.

    2. Editorial Policies

    2.1 Peer Review Policy

    Applied Biosafety
    adheres to a double-blind reviewing policy in which the identity of both the reviewer and author are always concealed from both parties. Please remove authors’ names and other identifying information from the manuscript, including the title page, text, and acknowledgments. Manuscripts are blinded to reviewers. Manuscripts that are not blinded will be returned to the author without review. The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

    2.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,

    (ii) Drafted the article or revised it critically for important intellectual content,

    (iii) Approved the version to be published,

    (iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    2.3 Acknowledgments

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    Please list acknowledgments separately to facilitate blind peer review. Acknowledgments will be published at the end of the article, prior to your declaration of Conflicting Interests (if applicable), any notes, and your references.

    2.4 Funding

    Applied Biosafety requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgments page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    2.5 Declaration of Conflicting Interests

    A “Declaration of Conflicting Interests” statement must be included with your manuscript. If no conflict exists, please state that “The Author(s) declare(s) that there is no conflict of interest.” For guidance on conflict of interest statements, please see the ICMJE recommendations. The “Declaration of Conflicting Interests” statement appears in published articles after any acknowledgments and prior to the references

    2.6 Research Ethics and Patient Consent

    Medical research involving human subjects must be conducted according to the
    World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    2.7 Clinical Trials

    Applied Biosafety does not publish clinical trials.

    2.8 Research Involving Animals

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    2.9 Dual Use Agents of Concern

    Dual Use Research of Concern (DURC) is defined as life sciences research that, based on current understanding, can be reasonably anticipated to provide knowledge, information, products, or technologies that could be directly misapplied to pose a significant threat with broad potential consequences to public health and safety, agricultural crops and other plants, animals, the environment, materiel, or national security. (http://osp.od.nih.gov/office-biotechnology-activities/biosecurity/dual-u...). The editorial policies of Applied Biosafety support the minimization of biosecurity risk while promoting the exchange of information required to improve public, occupational, and environmental health.

    3. Publishing Policies

    3.1 Publication Ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

    3.1.1 Plagiarism

    Applied Biosafety and SAGE take issues of copyright infringement, plagiarism, or other breaches of best practice in publication very seriously.

    We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgment, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    3.1.2 Prior publication

    If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    3.2 Contributor’s Publishing Agreement

    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement, which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information, and the policies for government employees, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    3.3 Open Access and Author Archiving

    Applied Biosafety offers optional immediate open access publishing via the SAGE Choice program. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway. All articles published in Applied Biosafety become open-access two years after publication.

    3.4 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures, or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    4. Manuscript Preparation

    4.1 Word Processing Formats: Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout. Text should be standard 10 or 12 point. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    4.2 Journal Style: Prepare manuscripts according to the AMA style. Double-space all material, including the abstract, endnotes, references, quotations, appendixes, and tables. Do not use footnotes. Citations in the text should be numbered in the order of appearance in the text; references are then listed in numerical order. Endnotes and references should follow the text. Each table and figure should appear at the end of the document file.

    4.3 Title, Keywords, and Abstracts: For Applied Biosafety, include an abstract of no more than 250 words. To facilitate anonymous review, the name, affiliation, mailing address, phone and fax numbers, and e-mail address of each author should appear in a separate title page that is not included in the main document of a submitted paper. Please also list 4-6 keywords and any acknowledgments on the title page. For more information, see 1. Article types above.

    4.4 Author Names, Affiliations, and Corresponding Author: Where the family name or surname may be ambiguous (e.g., a multiword name), please indicate this clearly. Author affiliations should only reflect the institution(s) where the research was done and will not be changed post publication. Clearly indicate who will handle correspondence at all stages, and the corresponding author should list a permanent email address (which is not related to his/her institution) so that readers can reach the corresponding author after any future job/institution shifts.

    4.5 References: Applied Biosafety adheres to the AMA reference style. View the AMA guidelines to ensure your manuscript conforms to this reference style.

    4.6 Artwork Guidelines: For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit the Artwork Guidelines section in SAGE’s manuscript submission guidelines page. Figures supplied in color will appear in color online regardless of whether or not these illustrations are reproduced in color in the printed version. For specifically requested color reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article from the production editor.

    4.7 Guidelines for Submitting Supplemental Files: This journal is able to host approved supplemental materials online, alongside the full-text of articles. Supplemental files must be provided at submission so that they can undergo peer-review alongside the article. For more information, please refer to SAGE’s Guidelines for Authors on Supplemental Files.

    4.8 Maximizing Online Discoverability: The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting SAGE’s Journal Author Gateway Guidelines on how to Help Readers Find Your Article online.

    4.9 English Language Editing Services: SAGE Language Services can help authors with editing, translation, and formatting of the manuscript prior to journal submission. An author’s use of these services in no way guarantees that his or her submission will ultimately be accepted, and any costs incurred are the sole responsibility of the author. For further information, we encourage the authors to visit the SAGE Language services link.

    5. How to Submit Your Manuscript

    Applied Biosafety (APB) is hosted on SAGETrack: a web-based online submission and peer-review system powered by ScholarOne™ Manuscripts. Before submitting your manuscript, please ensure you carefully read and adhere to all the guidelines and instructions to authors provided herein, and then simply visit http://mc.manuscriptcentral.com/apb to login and submit your article online.

    Important note: If you are submitting to your journal via SAGETrack, please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online, please visit ScholarOne Online Help.

    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    6. Upon Acceptance and Publication

    6.1 SAGE Production: SAGE Production Editors maintain regular communication with journal editors and authors throughout the production process. Proofs of the article will be sent to the corresponding author for review.

    Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate.

    6.2 E-prints: SAGE provides authors a link to the electronic PDF, as well as opportunities to purchase reprints.

    6.3 OnlineFirst Publication: Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication. For more information please visit our Online First Fact Sheet.

    6.4 Promoting Your Article: If you think your article may be suitable for promotion, please flag this for the journal editor or your production contact at SAGE as early as possible in the publishing process. We have a variety of different promotional channels at our disposal to ensure your article reaches the widest possible audience. See Promote Your Article for more information.

    7. Further Information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Applied Biosafety editorial office as follows:

    Karen D. Savage
    karen@absaoffice.org
    (866) 425-1385 (toll free)
    or (847) 949-1517 

    Individual Subscription, E-access


    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Backfile Purchase, E-access (Content through 1998)


    Institutional Subscription, Print Only


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Individual, Single Print Issue


    Institutional, Single Print Issue